Baxter EBIT Margin 2010-2025 | BAX

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Baxter (BAX) over the last 10 years. The current EBIT profit margin for Baxter as of June 30, 2025 is .
Baxter EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2025-06-30 $10.89B $-0.03B -0.28%
2025-03-31 $10.77B $-0.04B -0.40%
2024-12-31 $10.64B $0.01B 0.13%
2024-09-30 $8.42B $0.87B 10.27%
2024-06-30 $8.32B $0.89B 10.68%
2024-03-31 $9.34B $0.69B 7.42%
2023-12-31 $10.36B $0.71B 6.82%
2023-09-30 $8.97B $-0.10B -1.13%
2023-06-30 $9.98B $-3.16B -31.68%
2023-03-31 $9.86B $-2.88B -29.19%
2022-12-31 $10.06B $-2.85B -28.29%
2022-09-30 $13.79B $-2.43B -17.63%
2022-06-30 $13.40B $0.96B 7.18%
2022-03-31 $12.91B $1.12B 8.70%
2021-12-31 $12.15B $1.35B 11.11%
2021-09-30 $12.45B $1.73B 13.92%
2021-06-30 $12.20B $1.69B 13.86%
2021-03-31 $11.82B $1.60B 13.51%
2020-12-31 $11.67B $1.62B 13.84%
2020-09-30 $11.53B $1.75B 15.14%
2020-06-30 $11.41B $1.78B 15.59%
2020-03-31 $11.53B $1.80B 15.60%
2019-12-31 $11.36B $1.77B 15.60%
2019-09-30 $11.14B $1.62B 14.56%
2019-06-30 $11.05B $1.50B 13.58%
2019-03-31 $11.06B $1.54B 13.88%
2018-12-31 $11.10B $1.58B 14.27%
2018-09-30 $11.08B $1.49B 13.42%
2018-06-30 $11.02B $1.40B 12.74%
2018-03-31 $10.79B $1.37B 12.67%
2017-12-31 $10.58B $1.29B 12.17%
2017-09-30 $10.43B $1.30B 12.49%
2017-06-30 $10.28B $1.19B 11.56%
2017-03-31 $10.26B $0.91B 8.87%
2016-12-31 $10.16B $0.75B 7.33%
2016-09-30 $10.12B $0.62B 6.13%
2016-06-30 $10.05B $0.53B 5.23%
2016-03-31 $9.94B $0.55B 5.48%
2015-12-31 $9.97B $0.45B 4.50%
2015-09-30 $10.15B $0.46B 4.55%
2015-06-30 $10.38B $0.59B 5.66%
2015-03-31 $12.06B $1.16B 9.61%
2014-12-31 $13.50B $1.74B 12.88%
2014-09-30 $15.03B $2.09B 13.93%
2014-06-30 $16.03B $2.53B 15.79%
2014-03-31 $15.55B $2.70B 17.36%
2013-12-31 $15.15B $2.74B 18.11%
2013-09-30 $14.33B $2.72B 18.99%
2013-06-30 $14.09B $2.84B 20.17%
2013-03-31 $14.00B $2.79B 19.95%
2012-12-31 $13.94B $2.77B 19.88%
2012-09-30 $14.03B $2.87B 20.47%
2012-06-30 $14.03B $2.84B 20.24%
2012-03-31 $14.00B $2.89B 20.68%
2011-12-31 $13.89B $2.95B 21.20%
2011-09-30 $13.80B $2.84B 20.61%
2011-06-30 $13.54B $2.88B 21.27%
2011-03-31 $13.20B $2.75B 20.82%
2010-12-31 $12.84B $2.14B 16.63%
2010-09-30 $12.82B $2.35B 18.31%
2010-06-30 $12.74B $2.30B 18.03%
2010-03-31 $12.67B $2.35B 18.52%
2009-12-31 $12.56B $2.88B 22.90%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.599B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.801B 26.83
Boston Scientific (BSX) United States $156.873B 37.41
Stryker (SYK) United States $150.304B 30.59
EssilorLuxottica (ESLOY) France $143.779B 0.00
Medtronic (MDT) Ireland $118.071B 16.65
Lonza Group Ag (LZAGY) Switzerland $49.982B 0.00
Haleon (HLN) United Kingdom $43.547B 24.90
ResMed (RMD) United States $41.283B 29.52
GE HealthCare Technologies (GEHC) United States $33.904B 15.94
Agilent Technologies (A) United States $33.716B 21.78
Terumo (TRUMY) Japan $26.887B 31.86
Koninklijke Philips (PHG) Netherlands $26.663B 17.64
Insulet (PODD) United States $23.536B 78.86
Zimmer Biomet Holdings (ZBH) United States $21.155B 13.47
Smith & Nephew SNATS (SNN) United Kingdom $16.315B 0.00
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.925B 29.11
Lantheus Holdings (LNTH) United States $3.865B 10.45
Envista Holdings (NVST) United States $3.530B 24.70
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Prestige Consumer Healthcare (PBH) United States $3.295B 14.62
Perrigo (PRGO) Ireland $3.287B 8.21
ICU Medical (ICUI) United States $3.126B 21.28
Haemonetics (HAE) United States $2.651B 11.83
LeMaitre Vascular (LMAT) United States $2.166B 46.45
Curaleaf Holdings (CURLF) Canada $2.148B 0.00
Acuren (TIC) United States $2.126B 0.00
QuidelOrtho (QDEL) United States $1.886B 11.87
Green Thumb Industries (GTBIF) United States $1.876B 80.57
AtriCure (ATRC) United States $1.854B 0.00
Tilray Brands (TLRY) Canada $1.508B 0.00
Phibro Animal Health (PAHC) United States $1.305B 15.41
Neogen (NEOG) United States $1.247B 19.79
AdaptHealth (AHCO) United States $1.246B 17.71
BioLife Solutions (BLFS) United States $1.218B 2543.00
InMode (INMD) Israel $0.960B 8.88
Kestra Medical Technologies (KMTS) United States $0.924B 0.00
Valneva SE (VALN) France $0.745B 0.00
Cresco Labs (CRLBF) United States $0.699B 0.00
SNDL (SNDL) Canada $0.665B 0.00
Verano Holdings (VRNOF) United States $0.611B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.595B 0.00
ZimVie (ZIMV) United States $0.535B 20.62
Evolus (EOLS) United States $0.490B 0.00
Surmodics (SRDX) United States $0.488B 0.00
VAREX IMAGING (VREX) United States $0.475B 16.36
CeriBell (CBLL) United States $0.425B 0.00
Sanuwave Health (SNWV) United States $0.380B 0.00
Owens & Minor (OMI) United States $0.378B 3.35
Canopy Growth (CGC) Canada $0.362B 0.00
TerrAscend (TSNDF) Canada $0.340B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.302B 0.00
Aurora Cannabis (ACB) Canada $0.301B 0.00
High Tide (HITI) Canada $0.292B 0.00
Omeros (OMER) United States $0.289B 0.00
Brainsway (BWAY) Israel $0.288B 58.69
Capricor Therapeutics (CAPR) United States $0.286B 0.00
Viemed Healthcare (VMD) United States $0.278B 21.12
TriSalus Life Sciences (TLSI) United States $0.254B 0.00
Cerus (CERS) United States $0.251B 0.00
OraSure Technologies (OSUR) United States $0.244B 0.00
Vireo Growth (VREOF) United States $0.238B 0.00
Organigram Global (OGI) Canada $0.224B 0.00
Quanterix (QTRX) United States $0.214B 0.00
Exagen (XGN) United States $0.210B 0.00
Utah Medical Products (UTMD) United States $0.196B 16.34
FitLife Brands (FTLF) United States $0.176B 21.66
Biote (BTMD) United States $0.166B 5.51
Jushi Holdings (JUSHF) United States $0.147B 0.00
Jin Medical (ZJYL) China $0.128B 0.00
Quipt Home Medical (QIPT) United States $0.115B 0.00
MacroGenics (MGNX) United States $0.109B 0.00
Fonar (FONR) United States $0.098B 12.66
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Apyx Medical (APYX) United States $0.075B 0.00
Agape ATP (ATPC) $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.055B 32.10
Zynex (ZYXI) United States $0.051B 0.00
Rockwell Medical (RMTI) United States $0.051B 0.00
Veru (VERU) United States $0.048B 0.00
Nephros (NEPH) United States $0.043B 33.75
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.037B 14.45
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Sharps Technology (STSS) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00